Liabilities / Assets
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
91st percentile
Higher net margin than 91% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
99th percentile
Faster asset growth than 99% of similar nonprofits.
Revenue Growth
91st percentile
Faster revenue growth than 91% of similar nonprofits.
Balance Sheet
Assets
Up$94,184
Up $87,108 (+1231%) from 2018
Net Assets
$94,184
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2018
Revenue And Expenses
Revenue
Up$176,118
Up $81,712 (+87%) from 2018
Expenses
Up$89,009
Up $1,179 (+1.3%) from 2018
Net Income
Up$87,109
Up $80,533 (+1225%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
Raise awareness education of amyloidosis and donations to further research at leading institutions such as the Mayo Clinics Amyloidosis Research Fund.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $94,184
- Liabilities
- $0
- Net assets
- $94,184
- Revenue
- $176,118
- Expenses
- $89,009
- Net income
- $87,109